Concord Drugs Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 538965

₹74.53

Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #141 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Concord Drugs Limited (this stock)	98	44.6	-13.0%	98.3%	—	41	60	49

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹110 Cr

EV / EBITDA

19.6x

EV / Sales

1.13x

Market cap / Sales

1.02x

Earnings yield

2.24%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 21 Cr, up 56.1% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	21	2	—	₹0.8400
March 31, 2026	36	1	1	₹0.4600
Dec. 31, 2025	17	0	0	₹0.1600
Sept. 30, 2025	23	0	—	₹0.2100
June 30, 2025	13	0	0	₹0.1100
March 31, 2025	1	-7	-7	₹0.0800
Dec. 31, 2024	11	1	0	₹0.2220
Sept. 30, 2024	12	0	0	₹0.0500
June 30, 2024	6	0	0	₹0.0120
March 31, 2024	14	-1	-0	₹-0.3500
Dec. 31, 2023	13	-0	-0	₹-0.2400
Sept. 30, 2023	7	1	1	₹0.5600
June 30, 2023	9	1	0	₹0.5220

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	21	36	17	23	—	1	—	12	—	14	—	7	—
Operating revenue	21	36	17	23	13	1	11	12	6	14	13	7	9
Other income	0	0	0	0	—	0	—	0	—	0	—	0	—
Operating expenses	19	34	16	22	12	7	9	11	6	14	12	6	7
Operating profit	2	1	1	1	1	-6	1	1	1	0	1	2	1
Operating profit margin	10.7%	4.0%	5.2%	4.3%	7.0%	-786.5%	12.2%	6.7%	11.5%	1.3%	4.4%	20.7%	15.9%
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	1	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	2	1	0	0	0	-7	1	0	0	-1	-0	1	1
Tax	0	0	0	0	0	0	0	0	0	-0	-0	0	0
Net profit	—	1	0	—	0	-7	0	0	0	-0	-0	1	0
EPS	0.84	0.46	0.16	0.21	0.11	0.08	0.22	0.05	0.01	-0.35	-0.24	0.56	0.52
Net profit (TTM)	—	—	—	—	-7	-7	-0	-1	-0	0	1	2	1
EPS (TTM)	1.67	0.94	0.56	0.62	0.46	0.36	-0.07	-0.53	-0.02	0.49	0.91	1.67	1.32

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	—	—	—	—	51^†	59^†	51^†	51^†	48^†	—	—
Operating revenue	20.3%	11.7%	89^†	30^†	43^†	51^†	59^†	51^†	51^†	48^†	52^†	58^†
Other income	—	—	—	—	—	0^†	0^†	0^†	0^†	0^†	—	—
Operating expenses	—	—	85^†	33^†	40^†	47^†	53^†	48^†	48^†	44^†	48^†	50^†
Operating profit	-0.8%	5.7%	4^†	-3^†	4^†	4^†	6^†	3^†	3^†	4^†	3^†	7^†
Operating profit margin	—	—	4.8%^†	-11.4%^†	8.5%^†	8.5%^†	9.5%^†	6.3%^†	6.6%^†	7.6%^†	6.6%^†	12.5%^†
Depreciation	—	—	1^†	1^†	2^†	2^†	2^†	1^†	1^†	2^†	2^†	3^†
Interest	—	—	1^†	2^†	2^†	2^†	2^†	1^†	2^†	2^†	2^†	2^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	4^†	0^†	0^†	0^†	0^†
Profit before tax	9.2%	-19.3%	1^†	-7^†	1^†	1^†	2^†	4^†	0^†	0^†	-1^†	1^†
Tax	—	—	0^†	0^†	0^†	0^†	1^†	1^†	0^†	0^†	0^†	0^†
Net profit	—	—	—	-7^†	0^†	1^†	2^†	3^†	0^†	0^†	-1^†	0^†
EPS	-2.4%	-24.2%	0.94^†	0.36^†	0.49^†	1.01^†	1.82^†	3.76^†	0.37^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	4.8%^†	-11.4%^†	8.5%^†	8.5%^†	9.5%^†	6.3%^†	6.6%^†	7.6%^†	6.6%^†	12.5%^†
EBIT margin	3.3%^†	-16.2%^†	5.0%^†	5.4%^†	6.7%^†	11.1%^†	3.9%^†	4.2%^†	2.4%^†	5.2%^†
PBT margin	1.6%^†	-21.9%^†	1.3%^†	2.2%^†	3.8%^†	8.4%^†	0.9%^†	0.9%^†	-1.4%^†	1.1%^†
Net margin	—	-23.1%^†	1.0%^†	1.7%^†	2.7%^†	6.4%^†	0.7%^†	0.8%^†	-1.7%^†	0.3%^†
Interest coverage	2.00x^†	-2.80x^†	1.35x^†	1.69x^†	2.34x^†	4.02x^†	1.31x^†	1.28x^†	0.62x^†	1.27x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	2.74x	1.70x	—	—	—	—	—	—	—	—
Quick ratio	1.73x	0.73x	—	—	—	—	—	—	—	—
Debt to equity	0.24x	0.44x	—	—	—	—	—	—	—	—
Return on equity	—	-20.2%^†	—	—	—	—	—	—	—	—
Return on assets	—	-11.7%^†	—	—	—	—	—	—	—	—
Return on capital employed	5.4%^†	-12.3%^†	—	—	—	—	—	—	—	—
Asset turnover	1.24x^†	0.51x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-7	-1	8	1	-8
March 31, 2025	4	-2	-1	2	1

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	72	49	35	10	2	49	18	0	11	18
March 31, 2025	59	34	24	14	1	33	20	0	12	19

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.